5-Methyl-MDA

Source: Wikipedia, the free encyclopedia.
5-Methyl-MDA
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
Identifiers
  • 1-(7-methyl-1,3-benzodioxol-5-yl)propan-2-amine
JSmol)
  • O2COc1c2cc(CC(N)C)cc1C
  • InChI=1S/C11H15NO2/c1-7-3-9(4-8(2)12)5-10-11(7)14-6-13-10/h3,5,8H,4,6,12H2,1-2H3 checkY
  • Key:OLENSVFSNAULML-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

5-Methyl-3,4-methylenedioxyamphetamine (5-Methyl-MDA) is an

MDMA.[1]

Effects and research

LSD, but not amphetamine, suggesting that it produces a mix of entactogen and hallucinogenic effects without any stimulant effects.[citation needed
]

5-Methyl-MDA acts as a

steric hindrance.[1][2]

Recent research has used data on 2-methyl-MDA and 5-methyl-MDA to help guide computer modeling of the serotonin transporter complex.[3]

Legal status

5-Methyl-MDA is not scheduled by the United Nations' Convention on Psychotropic Substances.[4]

United States

5-Methyl-MDA is not

possession could potentially be prosecuted under the Federal Analogue Act.[6]

References

  1. ^
    PMID 9526575
    .
  2. ^ PIHKAL #98
  3. PMID 18354055
    .
  4. ^ "Convention on Psychotropic Substances, 1971". Archived from the original on 2022-01-19. Retrieved 2016-06-09.
  5. ^ "§1308.11 Schedule I." Archived from the original on 2009-08-27. Retrieved 2016-06-09.
  6. ^ Erowid Analog Law Vault : Federal Controlled Substance Analogue Act Summary
Retrieved from "https://en.wikipedia.org/w/index.php?title=5-Methyl-MDA&oldid=1172538314"